AH
FOLD

Achievement Holdings’s Amicus Therapeutics FOLD Stock Holding History

Achievement Holdings’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-40,000
Closed -$560K – 50
2015
Q3 		$560K Sell
40,000
-10,000
-20% -$157K 0.05% 131
2015
Q2 		$708 Buy
+50,000
New +$601K 0.03% 177

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Achievement Holdings's FOLD Position: Q4 2015 in Review

Achievement Holdings sold out of Amicus Therapeutics (FOLD) in Q4 2015, closing a stake of 40,000 shares — an estimated $560K sold.

Achievement Holdings first reported a position in FOLD in Q2 2015 and held it in 2 quarters. The position peaked at $560K in Q3 2015. 139 funds tracked by Wall St. Rank hold FOLD as of Q4 2015.

  • Achievement Holdings reported no remaining Amicus Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Achievement Holdings sold 40,000 Amicus Therapeutics shares in Q4 2015, an estimated $560K.
  • Achievement Holdings first reported a position in Amicus Therapeutics in Q2 2015 and held it in 2 quarters.
  • Achievement Holdings's Amicus Therapeutics position peaked at $560K in Q3 2015.
  • 139 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2015.

Based on Achievement Holdings's 13F filing for Q4 2015.